Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
cancer drugs
clinical trials
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
3
×
cancer
deals
investing
ipo
revolution medicines
san francisco
sanofi
the column group
third rock ventures
warp drive bio
acute myeloid leukemia
alx oncology
amgen
autoimmune diseases
berkeley lights
biotech ipos
cancer immunotherapy
cd47
chronic kidney disease
cobimetinib
colorectal cancer
deerfield healthcare technology acquisitions
deerfield management company
europe blog main
europe top stories
fda
immunotherapy
kidney disease
mark goldsmith
medicare
What
ipo
3
×
research
3
×
cancer
medicines
proteins
revolution
arrival
biotech
cancer’s
companies
days
despite
disease
drug
family
frontiers
hardest
hasn’t
hit
hottest
hunters
industry
ipos
known
life
maps
market
momentum
new
parlance
pharmaceutical
play
raised
ras
reach
reels
revealed
role
science
slowed
Language
unset
Current search:
research
×
ipo
×
" san francisco top stories "
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers